Franklin joint replacement device firm Arthrosurface has received clearance from the U.S. Food and Drug Administration to market a new knee device.Â
The Patellofemoral Wave Kahuna Arthroplasty System is designed to restore a patient’s patella and femoral trochlea while maintaining the anatomy of the rest of the knee.
The new product is an extension of the company’s HemiCAP Patellofemoral & PF Wave Systems. The Kahuna implant, however, is larger and gives surgeons a wider range of options to better suit a patient’s needs.
The clearance comes shortly after the European Society for Sports Traumatology, Knee Surgery and Arthroscopy confirmed the device improves postoperative outcomes with no progression of knee arthritis after five years.
